| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_edb96c9605b1cfb33530817f7a6b058e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5858f673a3b5f6ecd529a0f3f87423b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b40b7deef3c1628b806fdd2f032c1c21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c7c2bd914974f31a359959d683921a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9aea9dcbcba5109cd419513d47b1b1cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7cdb09a9b086fdc245a42792391c86e4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2821 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate |
2006-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29b417536d90d89fd0efd5c511016302
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f991dbdff5d69b2e1fb9c2880a4856e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3be525af4f89c78012841d6e8ac85690
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5598cdcc73dd81c19c4d6fad6ce8421d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d7e4cb6bf93795a5afc821964945e27 |
| publicationDate |
2007-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006113289-A9 |
| titleOfInvention |
Saposin d and fam3c are biomarkers for alzheimer's disease |
| abstract |
The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying Alzheimer's disease status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as Alzheimer's disease or non-Alzheimer's disease. The biomarkers can be detected by SELDI mass spectrometry. |
| priorityDate |
2005-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |